# Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients

> **NCT02111954** · — · COMPLETED · sponsor: **University of Lausanne Hospitals** · enrollment: 60 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 1 PET/CT with F-18-FCH + 1 PET/CT with Ga-68-NODAGA-MJ9

## Key facts

- **NCT ID:** NCT02111954
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-10-28
- **Final completion:** 2016-10-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111954, "Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02111954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*